Pain control during endometrial sampling compared among Lidocaine gel, Lidocaine spray and placebo in Nakornping hospital: A randomized-controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20250916008

Enrollment

105

Registered

2025-09-16

Start date

2025-02-03

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women with abnormal uterine bleeding age at 35 years old and above Abnormal uterine bleeding Endometrial sampling Lidocaine gel Lidocaine spray

Interventions

Lidocaine gel 3cc apply cervix 3 minutes before procedure,Lidocaine spray 5puff apply cervix 3 minutes before procedure,KY-gel 3cc apply cervix 3 minutes before procedure

Active Comparator Drug,Active Comparator Drug,Placebo Comparator No treatment

Lidocaine gel,Lidocaine spray,Placebo

Eligibility

Sex/Gender

Female

Age

35 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. women age at 35 years old and above 2. history of abnormal uterine bleeding 3. Can read or understand Thai languages

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Other cervical bleeding e.g. cervical cancer, cervical polyp, prolapsed submucous myoma 3. Bleeding tendency 4. History of Lidocaine allergy

Design outcomes

Primary

Measure	Time frame
Pain Score start to 10 minutes Visual Analog Scale	—

Secondary

Measure	Time frame
Safety of Lidocaine gel, Lidocaine spray 10 minutes Observe local effect	—

Countries

Thailand

Contacts

Public ContactNongyao Uatrongjit

Nakornping hospital

nongyao.ob.nkp@gmail.com053999200

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026